Shlyakhto, V. (2016). Initial decline of BCR-ABL transcript levels as early prognostic marker for patients with chronic myeloid leukemia (CML) treated with imatinib.
Chicago-Zitierstil (17. Ausg.)Shlyakhto, Valeria. Initial Decline of BCR-ABL Transcript Levels as Early Prognostic Marker for Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib. Heidelberg, 2016.
MLA-Zitierstil (9. Ausg.)Shlyakhto, Valeria. Initial Decline of BCR-ABL Transcript Levels as Early Prognostic Marker for Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib. 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.